nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—CYP1A2—chronic obstructive pulmonary disease	0.245	0.634	CbGaD
Rosiglitazone—ALB—chronic obstructive pulmonary disease	0.141	0.366	CbGaD
Rosiglitazone—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0603	0.13	CbGbCtD
Rosiglitazone—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0603	0.13	CbGbCtD
Rosiglitazone—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0457	0.0987	CbGbCtD
Rosiglitazone—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0391	0.0844	CbGbCtD
Rosiglitazone—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0268	0.0579	CbGbCtD
Rosiglitazone—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.025	0.0539	CbGbCtD
Rosiglitazone—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.025	0.0539	CbGbCtD
Rosiglitazone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0225	0.0487	CbGbCtD
Rosiglitazone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0207	0.0448	CbGbCtD
Rosiglitazone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0207	0.0448	CbGbCtD
Rosiglitazone—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0196	0.0423	CbGbCtD
Rosiglitazone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.019	0.041	CbGbCtD
Rosiglitazone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.019	0.041	CbGbCtD
Rosiglitazone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0169	0.0365	CbGbCtD
Rosiglitazone—ALB—Prednisone—chronic obstructive pulmonary disease	0.0162	0.0349	CbGbCtD
Rosiglitazone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0157	0.034	CbGbCtD
Rosiglitazone—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0105	0.0226	CbGbCtD
Rosiglitazone—PPARG—leg—chronic obstructive pulmonary disease	0.00314	0.204	CbGeAlD
Rosiglitazone—ACSL4—respiratory system—chronic obstructive pulmonary disease	0.00174	0.113	CbGeAlD
Rosiglitazone—ACSL4—connective tissue—chronic obstructive pulmonary disease	0.00153	0.0991	CbGeAlD
Rosiglitazone—ACSL4—bronchus—chronic obstructive pulmonary disease	0.00143	0.0926	CbGeAlD
Rosiglitazone—ACSL4—trachea—chronic obstructive pulmonary disease	0.00128	0.0832	CbGeAlD
Rosiglitazone—ACSL4—lung—chronic obstructive pulmonary disease	0.000922	0.0598	CbGeAlD
Rosiglitazone—PPARG—respiratory system—chronic obstructive pulmonary disease	0.000781	0.0506	CbGeAlD
Rosiglitazone—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.000753	0.00883	CcSEcCtD
Rosiglitazone—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000733	0.0086	CcSEcCtD
Rosiglitazone—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.000706	0.00829	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Salbutamol—chronic obstructive pulmonary disease	0.000689	0.00808	CcSEcCtD
Rosiglitazone—PPARG—connective tissue—chronic obstructive pulmonary disease	0.000688	0.0446	CbGeAlD
Rosiglitazone—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.000683	0.00801	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.000656	0.0077	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.000656	0.0077	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.00758	CcSEcCtD
Rosiglitazone—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000645	0.00757	CcSEcCtD
Rosiglitazone—PPARG—smooth muscle tissue—chronic obstructive pulmonary disease	0.000629	0.0408	CbGeAlD
Rosiglitazone—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00061	0.00715	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00061	0.00715	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00061	0.00715	CcSEcCtD
Rosiglitazone—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000601	0.00705	CcSEcCtD
Rosiglitazone—Increased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.00702	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000592	0.00695	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000576	0.00676	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.000575	0.00675	CcSEcCtD
Rosiglitazone—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000573	0.00672	CcSEcCtD
Rosiglitazone—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000565	0.00663	CcSEcCtD
Rosiglitazone—Hypertriglyceridaemia—Prednisone—chronic obstructive pulmonary disease	0.000562	0.00659	CcSEcCtD
Rosiglitazone—Multiple fractures—Prednisone—chronic obstructive pulmonary disease	0.000555	0.00651	CcSEcCtD
Rosiglitazone—Fracture—Prednisone—chronic obstructive pulmonary disease	0.000555	0.00651	CcSEcCtD
Rosiglitazone—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000533	0.00626	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000532	0.00624	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000532	0.00624	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000525	0.00616	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000521	0.00612	CcSEcCtD
Rosiglitazone—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000503	0.0059	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.0059	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000501	0.00588	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000498	0.00584	CcSEcCtD
Rosiglitazone—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000497	0.00583	CcSEcCtD
Rosiglitazone—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000493	0.00578	CcSEcCtD
Rosiglitazone—Blood triglycerides increased—Prednisone—chronic obstructive pulmonary disease	0.000492	0.00578	CcSEcCtD
Rosiglitazone—CYP2A6—lung—chronic obstructive pulmonary disease	0.000487	0.0316	CbGeAlD
Rosiglitazone—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000482	0.0312	CbGeAlD
Rosiglitazone—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.00561	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000478	0.00561	CcSEcCtD
Rosiglitazone—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.00559	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000468	0.00549	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000464	0.00544	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000464	0.00544	CcSEcCtD
Rosiglitazone—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000461	0.00541	CcSEcCtD
Rosiglitazone—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000458	0.00537	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000452	0.0053	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.0053	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.0053	CcSEcCtD
Rosiglitazone—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.00527	CcSEcCtD
Rosiglitazone—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00045	0.00527	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00523	CcSEcCtD
Rosiglitazone—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000444	0.00521	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00514	CcSEcCtD
Rosiglitazone—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00043	0.00505	CcSEcCtD
Rosiglitazone—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.00505	CcSEcCtD
Rosiglitazone—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00043	0.00504	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000425	0.00498	CcSEcCtD
Rosiglitazone—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.000422	0.00495	CcSEcCtD
Rosiglitazone—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000421	0.00494	CcSEcCtD
Rosiglitazone—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000418	0.0271	CbGeAlD
Rosiglitazone—PPARG—lung—chronic obstructive pulmonary disease	0.000415	0.0269	CbGeAlD
Rosiglitazone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000414	0.00485	CcSEcCtD
Rosiglitazone—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00477	CcSEcCtD
Rosiglitazone—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00476	CcSEcCtD
Rosiglitazone—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000406	0.00476	CcSEcCtD
Rosiglitazone—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000406	0.00476	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00475	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00475	CcSEcCtD
Rosiglitazone—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000403	0.00473	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00465	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.000395	0.00464	CcSEcCtD
Rosiglitazone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000394	0.00463	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000384	0.00451	CcSEcCtD
Rosiglitazone—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.0045	CcSEcCtD
Rosiglitazone—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00448	CcSEcCtD
Rosiglitazone—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00448	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.00448	CcSEcCtD
Rosiglitazone—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000382	0.00448	CcSEcCtD
Rosiglitazone—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00447	CcSEcCtD
Rosiglitazone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000381	0.00447	CcSEcCtD
Rosiglitazone—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000378	0.00444	CcSEcCtD
Rosiglitazone—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000378	0.00444	CcSEcCtD
Rosiglitazone—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000377	0.00442	CcSEcCtD
Rosiglitazone—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000374	0.00439	CcSEcCtD
Rosiglitazone—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00436	CcSEcCtD
Rosiglitazone—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00436	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000371	0.00435	CcSEcCtD
Rosiglitazone—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000368	0.0238	CbGeAlD
Rosiglitazone—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00427	CcSEcCtD
Rosiglitazone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000363	0.00426	CcSEcCtD
Rosiglitazone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000363	0.00426	CcSEcCtD
Rosiglitazone—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000362	0.00425	CcSEcCtD
Rosiglitazone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000361	0.00424	CcSEcCtD
Rosiglitazone—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00423	CcSEcCtD
Rosiglitazone—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00036	0.00422	CcSEcCtD
Rosiglitazone—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00421	CcSEcCtD
Rosiglitazone—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00421	CcSEcCtD
Rosiglitazone—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.00417	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.00417	CcSEcCtD
Rosiglitazone—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00412	CcSEcCtD
Rosiglitazone—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00407	CcSEcCtD
Rosiglitazone—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00407	CcSEcCtD
Rosiglitazone—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.00402	CcSEcCtD
Rosiglitazone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000342	0.00402	CcSEcCtD
Rosiglitazone—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000341	0.004	CcSEcCtD
Rosiglitazone—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00397	CcSEcCtD
Rosiglitazone—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000336	0.0218	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00033	0.00387	CcSEcCtD
Rosiglitazone—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00384	CcSEcCtD
Rosiglitazone—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00384	CcSEcCtD
Rosiglitazone—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00384	CcSEcCtD
Rosiglitazone—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00376	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000313	0.00367	CcSEcCtD
Rosiglitazone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00031	0.00364	CcSEcCtD
Rosiglitazone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00363	CcSEcCtD
Rosiglitazone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00363	CcSEcCtD
Rosiglitazone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00363	CcSEcCtD
Rosiglitazone—PTGS1—trachea—chronic obstructive pulmonary disease	0.000309	0.02	CbGeAlD
Rosiglitazone—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00359	CcSEcCtD
Rosiglitazone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000305	0.00358	CcSEcCtD
Rosiglitazone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.00358	CcSEcCtD
Rosiglitazone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000305	0.00358	CcSEcCtD
Rosiglitazone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000305	0.00358	CcSEcCtD
Rosiglitazone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.00358	CcSEcCtD
Rosiglitazone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000299	0.00351	CcSEcCtD
Rosiglitazone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000299	0.00351	CcSEcCtD
Rosiglitazone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00343	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00343	CcSEcCtD
Rosiglitazone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00343	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00343	CcSEcCtD
Rosiglitazone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00343	CcSEcCtD
Rosiglitazone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000291	0.00341	CcSEcCtD
Rosiglitazone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000291	0.00341	CcSEcCtD
Rosiglitazone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00338	CcSEcCtD
Rosiglitazone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00338	CcSEcCtD
Rosiglitazone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000288	0.00338	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00337	CcSEcCtD
Rosiglitazone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00337	CcSEcCtD
Rosiglitazone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00337	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000287	0.00336	CcSEcCtD
Rosiglitazone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000287	0.00336	CcSEcCtD
Rosiglitazone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000285	0.00334	CcSEcCtD
Rosiglitazone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000281	0.0033	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00329	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00324	CcSEcCtD
Rosiglitazone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00324	CcSEcCtD
Rosiglitazone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00322	CcSEcCtD
Rosiglitazone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000272	0.00319	CcSEcCtD
Rosiglitazone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00318	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00316	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000267	0.00313	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.00313	CcSEcCtD
Rosiglitazone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00309	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00306	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00303	CcSEcCtD
Rosiglitazone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00301	CcSEcCtD
Rosiglitazone—CYP1A2—lung—chronic obstructive pulmonary disease	0.000256	0.0166	CbGeAlD
Rosiglitazone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000254	0.00298	CcSEcCtD
Rosiglitazone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.00297	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00296	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00296	CcSEcCtD
Rosiglitazone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00296	CcSEcCtD
Rosiglitazone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00296	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00295	CcSEcCtD
Rosiglitazone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00293	CcSEcCtD
Rosiglitazone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00293	CcSEcCtD
Rosiglitazone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00292	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000247	0.0029	CcSEcCtD
Rosiglitazone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000247	0.0029	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.00287	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00286	CcSEcCtD
Rosiglitazone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00284	CcSEcCtD
Rosiglitazone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00284	CcSEcCtD
Rosiglitazone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000241	0.00282	CcSEcCtD
Rosiglitazone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00282	CcSEcCtD
Rosiglitazone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.00281	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.0028	CcSEcCtD
Rosiglitazone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00279	CcSEcCtD
Rosiglitazone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00277	CcSEcCtD
Rosiglitazone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00273	CcSEcCtD
Rosiglitazone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00273	CcSEcCtD
Rosiglitazone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00268	CcSEcCtD
Rosiglitazone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00268	CcSEcCtD
Rosiglitazone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000228	0.00268	CcSEcCtD
Rosiglitazone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00267	CcSEcCtD
Rosiglitazone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000227	0.00266	CcSEcCtD
Rosiglitazone—PTGS1—lung—chronic obstructive pulmonary disease	0.000222	0.0144	CbGeAlD
Rosiglitazone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00257	CcSEcCtD
Rosiglitazone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000215	0.00253	CcSEcCtD
Rosiglitazone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00246	CcSEcCtD
Rosiglitazone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00246	CcSEcCtD
Rosiglitazone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00243	CcSEcCtD
Rosiglitazone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00243	CcSEcCtD
Rosiglitazone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00241	CcSEcCtD
Rosiglitazone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00238	CcSEcCtD
Rosiglitazone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00235	CcSEcCtD
Rosiglitazone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00235	CcSEcCtD
Rosiglitazone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00232	CcSEcCtD
Rosiglitazone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000196	0.0023	CcSEcCtD
Rosiglitazone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00229	CcSEcCtD
Rosiglitazone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00227	CcSEcCtD
Rosiglitazone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00227	CcSEcCtD
Rosiglitazone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00222	CcSEcCtD
Rosiglitazone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00222	CcSEcCtD
Rosiglitazone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00216	CcSEcCtD
Rosiglitazone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00216	CcSEcCtD
Rosiglitazone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00216	CcSEcCtD
Rosiglitazone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00216	CcSEcCtD
Rosiglitazone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00216	CcSEcCtD
Rosiglitazone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00215	CcSEcCtD
Rosiglitazone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00215	CcSEcCtD
Rosiglitazone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00214	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00214	CcSEcCtD
Rosiglitazone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00212	CcSEcCtD
Rosiglitazone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00212	CcSEcCtD
Rosiglitazone—Headache—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00211	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00209	CcSEcCtD
Rosiglitazone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00208	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00208	CcSEcCtD
Rosiglitazone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00204	CcSEcCtD
Rosiglitazone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00204	CcSEcCtD
Rosiglitazone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00204	CcSEcCtD
Rosiglitazone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00204	CcSEcCtD
Rosiglitazone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00203	CcSEcCtD
Rosiglitazone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00017	0.002	CcSEcCtD
Rosiglitazone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.00197	CcSEcCtD
Rosiglitazone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00192	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00187	CcSEcCtD
Rosiglitazone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00186	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00186	CcSEcCtD
Rosiglitazone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00178	CcSEcCtD
Rosiglitazone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00172	CcSEcCtD
Rosiglitazone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00165	CcSEcCtD
Rosiglitazone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00153	CcSEcCtD
Rosiglitazone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00151	CcSEcCtD
Rosiglitazone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00148	CcSEcCtD
Rosiglitazone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00143	CcSEcCtD
Rosiglitazone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00141	CcSEcCtD
Rosiglitazone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00141	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00135	CcSEcCtD
Rosiglitazone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00135	CcSEcCtD
Rosiglitazone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00134	CcSEcCtD
Rosiglitazone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00132	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00123	CcSEcCtD
Rosiglitazone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00123	CcSEcCtD
Rosiglitazone—Rash—Prednisolone—chronic obstructive pulmonary disease	9.99e-05	0.00117	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.98e-05	0.00117	CcSEcCtD
Rosiglitazone—Fatigue—Prednisone—chronic obstructive pulmonary disease	9.93e-05	0.00116	CcSEcCtD
Rosiglitazone—Headache—Prednisolone—chronic obstructive pulmonary disease	9.93e-05	0.00116	CcSEcCtD
Rosiglitazone—Constipation—Prednisone—chronic obstructive pulmonary disease	9.84e-05	0.00115	CcSEcCtD
Rosiglitazone—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.41e-05	0.0011	CcSEcCtD
Rosiglitazone—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.00107	CcSEcCtD
Rosiglitazone—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000969	CcSEcCtD
Rosiglitazone—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.15e-05	0.000956	CcSEcCtD
Rosiglitazone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.000924	CcSEcCtD
Rosiglitazone—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.000893	CcSEcCtD
Rosiglitazone—Rash—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000852	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000851	CcSEcCtD
Rosiglitazone—Headache—Prednisone—chronic obstructive pulmonary disease	7.21e-05	0.000846	CcSEcCtD
Rosiglitazone—Nausea—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.000802	CcSEcCtD
Rosiglitazone—PPARG—Adipogenesis—TNF—chronic obstructive pulmonary disease	4.47e-05	0.000887	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.45e-05	0.000883	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.45e-05	0.000883	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.29e-05	0.000851	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.28e-05	0.000849	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	4.25e-05	0.000843	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.25e-05	0.000843	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.19e-05	0.000831	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.18e-05	0.00083	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.13e-05	0.000819	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.07e-05	0.000807	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.03e-05	0.000799	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.02e-05	0.000797	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.97e-05	0.000788	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.81e-05	0.000757	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.79e-05	0.000753	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.79e-05	0.000752	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	3.79e-05	0.000751	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.77e-05	0.000748	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.76e-05	0.000746	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.74e-05	0.000743	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.74e-05	0.000742	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.73e-05	0.000741	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.71e-05	0.000736	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.7e-05	0.000735	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	3.63e-05	0.000721	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—IL6—chronic obstructive pulmonary disease	3.61e-05	0.000716	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.59e-05	0.000713	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.58e-05	0.000709	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.54e-05	0.000703	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.49e-05	0.000692	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.46e-05	0.000686	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.46e-05	0.000686	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.46e-05	0.000686	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.46e-05	0.000686	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.45e-05	0.000685	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.44e-05	0.000682	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.43e-05	0.000681	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.42e-05	0.000679	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.42e-05	0.000678	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.41e-05	0.000676	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.39e-05	0.000673	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.39e-05	0.000673	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.38e-05	0.00067	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ALB—chronic obstructive pulmonary disease	3.37e-05	0.000669	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.32e-05	0.000659	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.32e-05	0.000659	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.31e-05	0.000656	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.3e-05	0.000654	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.29e-05	0.000654	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.28e-05	0.00065	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.000647	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.26e-05	0.000647	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.24e-05	0.000643	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.23e-05	0.000641	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	3.23e-05	0.000641	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.23e-05	0.000641	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.23e-05	0.000641	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.22e-05	0.00064	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.22e-05	0.000639	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.21e-05	0.000638	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.18e-05	0.00063	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.17e-05	0.000629	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.14e-05	0.000623	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.06e-05	0.000606	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.05e-05	0.000605	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.03e-05	0.0006	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.02e-05	0.0006	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3e-05	0.000596	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.95e-05	0.000586	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.92e-05	0.00058	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.91e-05	0.000578	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.9e-05	0.000575	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.89e-05	0.000574	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.89e-05	0.000573	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.84e-05	0.000564	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.8e-05	0.000556	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.79e-05	0.000554	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.78e-05	0.000552	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.77e-05	0.000549	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.000548	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.75e-05	0.000545	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.72e-05	0.00054	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.69e-05	0.000534	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.66e-05	0.000528	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.64e-05	0.000523	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.62e-05	0.00052	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.55e-05	0.000505	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.52e-05	0.0005	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GCLC—chronic obstructive pulmonary disease	2.49e-05	0.000494	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.39e-05	0.000475	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.35e-05	0.000466	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.32e-05	0.000461	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.31e-05	0.000458	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.3e-05	0.000456	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CTGF—chronic obstructive pulmonary disease	2.27e-05	0.000451	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.25e-05	0.000447	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.23e-05	0.000443	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.22e-05	0.00044	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.15e-05	0.000426	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.13e-05	0.000423	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.13e-05	0.000422	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.12e-05	0.000421	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.12e-05	0.00042	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.09e-05	0.000416	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.09e-05	0.000414	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.08e-05	0.000412	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.06e-05	0.000409	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2e-05	0.000396	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.98e-05	0.000394	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.96e-05	0.000389	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.94e-05	0.000385	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.93e-05	0.000383	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.92e-05	0.00038	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.9e-05	0.000377	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.88e-05	0.000373	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.86e-05	0.00037	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.83e-05	0.000363	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.79e-05	0.000356	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.79e-05	0.000355	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.77e-05	0.00035	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.76e-05	0.00035	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.75e-05	0.000347	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.75e-05	0.000347	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.75e-05	0.000346	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.74e-05	0.000345	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.73e-05	0.000344	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.73e-05	0.000344	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.72e-05	0.000342	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.71e-05	0.00034	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.7e-05	0.000337	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.67e-05	0.000331	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.65e-05	0.000328	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.65e-05	0.000327	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000327	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.65e-05	0.000326	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.63e-05	0.000323	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.61e-05	0.00032	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.61e-05	0.000319	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.61e-05	0.000318	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.59e-05	0.000316	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.59e-05	0.000316	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.58e-05	0.000313	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000307	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.54e-05	0.000305	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.54e-05	0.000305	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.53e-05	0.000304	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.000302	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.51e-05	0.000301	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.51e-05	0.000299	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.49e-05	0.000296	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.49e-05	0.000295	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.47e-05	0.000291	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.45e-05	0.000288	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.41e-05	0.000279	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.39e-05	0.000275	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.000274	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.000273	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.37e-05	0.000271	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.36e-05	0.000269	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.35e-05	0.000268	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.33e-05	0.000264	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000251	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.00025	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.24e-05	0.000246	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.22e-05	0.000243	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.21e-05	0.000239	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000238	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.16e-05	0.00023	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.15e-05	0.000228	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.14e-05	0.000226	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.14e-05	0.000226	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.13e-05	0.000225	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.000224	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-05	0.000223	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.12e-05	0.000222	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.1e-05	0.000218	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	0.000213	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.07e-05	0.000212	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.000211	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000209	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-05	0.000205	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000204	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.000203	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.02e-05	0.000202	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.0002	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.01e-05	0.0002	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—NOS3—chronic obstructive pulmonary disease	9.89e-06	0.000196	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.48e-06	0.000188	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.42e-06	0.000187	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.38e-06	0.000186	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.36e-06	0.000186	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.28e-06	0.000184	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.25e-06	0.000184	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.18e-06	0.000182	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.17e-06	0.000182	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.55e-06	0.00017	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.46e-06	0.000168	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.44e-06	0.000168	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.37e-06	0.000166	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	8.15e-06	0.000162	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.93e-06	0.000157	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.91e-06	0.000157	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.9e-06	0.000157	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.86e-06	0.000156	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.84e-06	0.000156	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.8e-06	0.000155	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.79e-06	0.000155	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.78e-06	0.000154	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.75e-06	0.000154	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.71e-06	0.000153	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.31e-06	0.000145	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.26e-06	0.000144	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.26e-06	0.000144	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	7.25e-06	0.000144	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.22e-06	0.000143	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.15e-06	0.000142	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.06e-06	0.00014	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.96e-06	0.000138	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.93e-06	0.000138	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.89e-06	0.000137	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	6.85e-06	0.000136	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.85e-06	0.000136	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.55e-06	0.00013	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.49e-06	0.000129	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.48e-06	0.000129	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.43e-06	0.000128	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.4e-06	0.000127	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.34e-06	0.000126	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.15e-06	0.000122	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	5.98e-06	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.96e-06	0.000118	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.91e-06	0.000117	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.65e-06	0.000112	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.6e-06	0.000111	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.5e-06	0.000109	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.42e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.05e-06	0.0001	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.79e-06	9.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.68e-06	9.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.48e-06	8.88e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.45e-06	8.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.18e-06	8.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4e-06	7.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.84e-06	7.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.81e-06	7.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.68e-06	7.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.64e-06	7.23e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.26e-06	6.46e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.11e-06	6.18e-05	CbGpPWpGaD
